Abstract |
The antitumorigenic activities of 6-methyl-1,3,8-trichlorodibenzofuran (6-MCDF), 8-methyl-1,3,6-trichlorodibenzofuran (8-MCDF) and 6-cyclohexyl-1,3,8-trichlorodibenzofuran (6-CHDF) were investigated in the 7,12-dimethylbenz[a] anthracene (DMBA) rat mammary tumor model. At doses of 5, 10 or 25 mg/kg/week, both 6-MCDF and 8-MCDF significantly inhibited mammary tumor growth and at the 5 mg/kg/week dose >50% growth inhibition was observed. In contrast, 6-CHDF was inactive at the 5 mg/kg/week dose and the structure-antitumorigenicity relationships (6- MCDF/8- MCDF > 6-CHDF) correlated with structure-antiestrogenicity (rat uterus) studies and the relative binding affinities of these compounds for the aryl hydrocarbon receptor (AhR). The antitumorigenic activity of 6-MCDF or 8-MCDF in the mammary was not accompanied by any significant changes in liver/ body weight ratios, liver morphology or induction of hepatic CYP1A1-dependent activity which is one of the most sensitive indicators of exposure to AhR agonists. RT-PCR and Western blot analysis of mammary tumor mRNA and protein extracts, respectively, confirmed the presence of AhR suggesting that AhR-mediated signaling pathways are functional in rat mammary tumors. These results define a relatively non-toxic group of AhR agonists which exhibit potent antitumorigenic activity in the DMBA-induced rat mammary tumor model (<1 mg/kg/day), and therefore represent a new class of indirect-acting antiestrogens which have potential for clinical treatment of mammary cancer.
|
Authors | A McDougal, C Wilson, S Safe |
Journal | Cancer letters
(Cancer Lett)
Vol. 120
Issue 1
Pg. 53-63
(Nov 25 1997)
ISSN: 0304-3835 [Print] Ireland |
PMID | 9570386
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- 8-methyl-1,3,8-trichlorodibenzofuran
- ARNT protein, rat
- Antineoplastic Agents
- Benzofurans
- DNA-Binding Proteins
- Estrogen Antagonists
- Receptors, Aryl Hydrocarbon
- Transcription Factors
- 6-methyl-1,3,8-trichlorodibenzofuran
- Aryl Hydrocarbon Receptor Nuclear Translocator
- 9,10-Dimethyl-1,2-benzanthracene
- Cytochrome P-450 CYP1A1
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
- Animals
- Antineoplastic Agents
(therapeutic use)
- Aryl Hydrocarbon Receptor Nuclear Translocator
- Benzofurans
(therapeutic use)
- Cytochrome P-450 CYP1A1
(genetics)
- DNA-Binding Proteins
- Estrogen Antagonists
(therapeutic use)
- Female
- Gene Expression Regulation, Neoplastic
(genetics)
- Mammary Neoplasms, Experimental
(chemically induced, pathology)
- Rats
- Rats, Sprague-Dawley
- Receptors, Aryl Hydrocarbon
(agonists, genetics)
- Transcription Factors
(genetics)
|